120 related articles for article (PubMed ID: 29498099)
1. Large number of cutaneous neurofibromas beyond age-appropriate incidence in a patient with a large deletion of NF1.
Yoshida Y; Ehara Y; Kosaki K; Yamamoto O
J Dermatol; 2018 Mar; 45(3):363-364. PubMed ID: 29498099
[No Abstract] [Full Text] [Related]
2. Natural course and characteristics of cutaneous neurofibromas in neurofibromatosis 1.
Ehara Y; Yamamoto O; Kosaki K; Yoshida Y
J Dermatol; 2018 Jan; 45(1):53-57. PubMed ID: 28891076
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis type 1 without cutaneous neurofibromas: a rare genotype-phenotype correlation?
Hida T; Idogawa M; Ishikawa A; Mizukami M; Kato J; Sumikawa Y; Okura M; Tokino T; Uhara H
Eur J Dermatol; 2020 Oct; 30(5):608-609. PubMed ID: 33185534
[No Abstract] [Full Text] [Related]
4. Phenotype-Genotype Correlation in Children with Neurofibromatosis Type 1.
Barrea C; Vaessen S; Bulk S; Harvengt J; Misson JP
Neuropediatrics; 2018 Jun; 49(3):180-184. PubMed ID: 29471550
[TBL] [Abstract][Full Text] [Related]
5. A genotype-phenotype correlation for quantitative autistic trait burden in neurofibromatosis 1.
Morris SM; Gutmann DH
Neurology; 2018 Feb; 90(8):377-379. PubMed ID: 29367450
[No Abstract] [Full Text] [Related]
6. Neurofibromatosis type 1: update on a common genetic condition.
Siqveland E; Pond D
Minn Med; 2009 Mar; 92(3):49-52. PubMed ID: 19400389
[TBL] [Abstract][Full Text] [Related]
7. Somatic neurofibromatosis type 1 (NF1) inactivation events in cutaneous neurofibromas of a single NF1 patient.
Emmerich D; Zemojtel T; Hecht J; Krawitz P; Spielmann M; Kühnisch J; Kobus K; Osswald M; Heinrich V; Berlien P; Müller U; Mautner VF; Wimmer K; Robinson PN; Vingron M; Tinschert S; Mundlos S; Kolanczyk M
Eur J Hum Genet; 2015 Jun; 23(6):870-3. PubMed ID: 25293717
[TBL] [Abstract][Full Text] [Related]
8. Simple method for estimating cutaneous neurofibromas in patients with neurofibromatosis 1.
Yoshida Y; Ehara Y; Noma H; Yamamoto O
J Dermatol; 2018 May; 45(5):626-627. PubMed ID: 29696709
[No Abstract] [Full Text] [Related]
9. A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands.
van Minkelen R; van Bever Y; Kromosoeto JN; Withagen-Hermans CJ; Nieuwlaat A; Halley DJ; van den Ouweland AM
Clin Genet; 2014 Apr; 85(4):318-27. PubMed ID: 23656349
[TBL] [Abstract][Full Text] [Related]
10. Dermoscopy of cutaneous neurofibromas associated with neurofibromatosis type 1.
Duman N; Elmas M
J Am Acad Dermatol; 2015 Sep; 73(3):529-31. PubMed ID: 26282805
[No Abstract] [Full Text] [Related]
11. Growth in neurofibromatosis 1 microdeletion patients.
Ning X; Farschtschi S; Jones A; Kehrer-Sawatzki H; Mautner VF; Friedman JM
Clin Genet; 2016 Mar; 89(3):351-4. PubMed ID: 26111455
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological Analysis of Major Complications Requiring Medical Intervention in Patients with Neurofibromatosis 1.
Yoshida Y; Ehara Y; Koga M; Imafuku S; Yamamoto O
Acta Derm Venereol; 2018 Aug; 98(8):753-756. PubMed ID: 29796689
[TBL] [Abstract][Full Text] [Related]
13. The presence and progression of choroidal neurofibromas in a predominantly pediatric population with neurofibromatosis type-1.
Chilibeck CM; Shah S; Russell HC; Vincent AL
Ophthalmic Genet; 2021 Jun; 42(3):223-229. PubMed ID: 33594930
[No Abstract] [Full Text] [Related]
14. Prevalence, Type, and Molecular Spectrum of
Pinna V; Daniele P; Calcagni G; Mariniello L; Criscione R; Giardina C; Lepri FR; Hozhabri H; Alberico A; Cavone S; Morella AT; Mandile R; Annunziata F; Di Giosaffatte N; D'Asdia MC; Versacci P; Capolino R; Strisciuglio P; Giustini S; Melis D; Digilio MC; Tartaglia M; Marino B; De Luca A
Genes (Basel); 2019 Sep; 10(9):. PubMed ID: 31487937
[TBL] [Abstract][Full Text] [Related]
15. Neurofibromatosis: novel and recurrent mutations in Turkish patients.
Terzi YK; Oguzkan S; Anlar B; Aysun S; Ayter S
Pediatr Neurol; 2007 Dec; 37(6):421-5. PubMed ID: 18021924
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.
Ferner RE; Huson SM; Thomas N; Moss C; Willshaw H; Evans DG; Upadhyaya M; Towers R; Gleeson M; Steiger C; Kirby A
J Med Genet; 2007 Feb; 44(2):81-8. PubMed ID: 17105749
[TBL] [Abstract][Full Text] [Related]
17. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
[TBL] [Abstract][Full Text] [Related]
18. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
[TBL] [Abstract][Full Text] [Related]
19. Clinical severity in Japanese patients with neurofibromatosis 1 based on DNB classification.
Ehara Y; Yamamoto O; Kosaki K; Yoshida Y
J Dermatol; 2017 Nov; 44(11):1262-1267. PubMed ID: 29098729
[TBL] [Abstract][Full Text] [Related]
20. Mutation spectrum of NF1 gene in Italian patients with neurofibromatosis type 1 using Ion Torrent PGM™ platform.
Calì F; Chiavetta V; Ruggeri G; Piccione M; Selicorni A; Palazzo D; Bonsignore M; Cereda A; Elia M; Failla P; Figura MG; Fiumara A; Maitz S; Luana Mandarà GM; Mattina T; Ragalmuto A; Romano C; Ruggieri M; Salluzzo R; Saporoso A; Schepis C; Sorge G; Spanò M; Tortorella G; Romano V
Eur J Med Genet; 2017 Feb; 60(2):93-99. PubMed ID: 27838393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
